Browse DKK3

Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Basic function annotation.
> Subcellular Location, Domain and Function
> Gene Ontology
> KEGG and Reactome Pathway
> Subcellular Location, Domain and Function
 
Subcellular Location Secreted.
Domain PF04706 Dickkopf N-terminal cysteine-rich region
Function

Antagonizes canonical Wnt signaling by inhibiting LRP5/6 interaction with Wnt and by forming a ternary complex with the transmembrane protein KREMEN that promotes internalization of LRP5/6. DKKs play an important role in vertebrate development, where they locally inhibit Wnt regulated processes such as antero-posterior axial patterning, limb development, somitogenesis and eye formation. In the adult, Dkks are implicated in bone formation and bone disease, cancer and Alzheimer disease (By similarity).

> Gene Ontology
 
Biological Process GO:0006081 cellular aldehyde metabolic process
GO:0006694 steroid biosynthetic process
GO:0006700 C21-steroid hormone biosynthetic process
GO:0006704 glucocorticoid biosynthetic process
GO:0006705 mineralocorticoid biosynthetic process
GO:0007178 transmembrane receptor protein serine/threonine kinase signaling pathway
GO:0007179 transforming growth factor beta receptor signaling pathway
GO:0008202 steroid metabolic process
GO:0008207 C21-steroid hormone metabolic process
GO:0008211 glucocorticoid metabolic process
GO:0008212 mineralocorticoid metabolic process
GO:0010565 regulation of cellular ketone metabolic process
GO:0010566 regulation of ketone biosynthetic process
GO:0010817 regulation of hormone levels
GO:0010894 negative regulation of steroid biosynthetic process
GO:0016055 Wnt signaling pathway
GO:0017015 regulation of transforming growth factor beta receptor signaling pathway
GO:0019216 regulation of lipid metabolic process
GO:0019218 regulation of steroid metabolic process
GO:0030111 regulation of Wnt signaling pathway
GO:0030178 negative regulation of Wnt signaling pathway
GO:0030325 adrenal gland development
GO:0031943 regulation of glucocorticoid metabolic process
GO:0031944 negative regulation of glucocorticoid metabolic process
GO:0031946 regulation of glucocorticoid biosynthetic process
GO:0031947 negative regulation of glucocorticoid biosynthetic process
GO:0032341 aldosterone metabolic process
GO:0032342 aldosterone biosynthetic process
GO:0032344 regulation of aldosterone metabolic process
GO:0032345 negative regulation of aldosterone metabolic process
GO:0032347 regulation of aldosterone biosynthetic process
GO:0032348 negative regulation of aldosterone biosynthetic process
GO:0032350 regulation of hormone metabolic process
GO:0032351 negative regulation of hormone metabolic process
GO:0032353 negative regulation of hormone biosynthetic process
GO:0034650 cortisol metabolic process
GO:0034651 cortisol biosynthetic process
GO:0034754 cellular hormone metabolic process
GO:0035270 endocrine system development
GO:0042180 cellular ketone metabolic process
GO:0042181 ketone biosynthetic process
GO:0042445 hormone metabolic process
GO:0042446 hormone biosynthetic process
GO:0044283 small molecule biosynthetic process
GO:0045833 negative regulation of lipid metabolic process
GO:0045939 negative regulation of steroid metabolic process
GO:0046184 aldehyde biosynthetic process
GO:0046885 regulation of hormone biosynthetic process
GO:0046890 regulation of lipid biosynthetic process
GO:0048732 gland development
GO:0050810 regulation of steroid biosynthetic process
GO:0051055 negative regulation of lipid biosynthetic process
GO:0060070 canonical Wnt signaling pathway
GO:0060828 regulation of canonical Wnt signaling pathway
GO:0071559 response to transforming growth factor beta
GO:0071560 cellular response to transforming growth factor beta stimulus
GO:0090030 regulation of steroid hormone biosynthetic process
GO:0090032 negative regulation of steroid hormone biosynthetic process
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:0090092 regulation of transmembrane receptor protein serine/threonine kinase signaling pathway
GO:0090287 regulation of cellular response to growth factor stimulus
GO:0198738 cell-cell signaling by wnt
GO:1901615 organic hydroxy compound metabolic process
GO:1901617 organic hydroxy compound biosynthetic process
GO:1902612 regulation of anti-Mullerian hormone signaling pathway
GO:1902613 negative regulation of anti-Mullerian hormone signaling pathway
GO:1903844 regulation of cellular response to transforming growth factor beta stimulus
GO:1990262 anti-Mullerian hormone signaling pathway
GO:2000064 regulation of cortisol biosynthetic process
GO:2000065 negative regulation of cortisol biosynthetic process
Molecular Function -
Cellular Component -
> KEGG and Reactome Pathway
 
KEGG -
Reactome -
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Literatures that report relations between DKK3 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells.
> Text Mining
 
  Literatures describing the relation between DKK3 and anti-tumor immunity in human cancer.
PMID Cancer type Relation to immunity Evidence sentences
26734010MelanomaInhibit immunity (infiltration)Increased CD8(+) T cell and reduced M2-type macrophages infiltration was observed in tumors inoculated together with DKK3-deficient MSCs.
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets.
> High-throughput Screening
  Statistical results of DKK3 in screening data sets for detecting immune reponses.
PMID Screening System Cancer Type Cell Line Data Set Statistical Results Relation to immunity
29301958CRISPR-Cas9 melanomaB16F10Pmel-1 T cell NA/NSNA/NS
29301958CRISPR-Cas9 melanomaB16F10OT-1 T cell NA/NSNA/NS
28783722CRISPR-Cas9 melanomaMel6242CT-CRISPR NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX+Anti-PD1 NA/NSNA/NS
28723893CRISPR-Cas9 melanomaB16GVAX NA/NSNA/NS
25691366RNAiBreast cancerMCF7Luc-CTL assay NA/NSNA/NS
24476824shRNAmelanomaB16Primary screen NA/NSNA/NS
24476824shRNAmelanomaB16Secondary screen NA/NSNA/NS
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets.
> Expression difference between responders and non-responders
> Mutation difference between responders and non-responders
> Expression difference between responders and non-responders
 
Points in the above scatter plot represent the expression difference of DKK3 in various data sets.
No PMID Cancer type Group Drug # Res # NRes Log2 (Fold Change) P value Anno
126997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)1412-1.8650.00473
226997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)65-2.5090.194
326997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)87-1.3820.302
428552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 916-0.1510.731
528552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 59-0.40.845
628552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470.1590.949
729033130MelanomaallAnti-PD-1 (nivolumab) 2623-0.150.796
829033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 1511-0.2450.868
929033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 11120.0460.976
1029301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 481.0050.625
1129301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 2001
1229301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 282.1470.448
1329443960Urothelial cancerallAnti-PD-L1 (atezolizumab) 68230-0.3580.00809
> Mutation difference between responders and non-responders
 
Points in the above scatter plot represent the mutation difference of DKK3 in various data sets.
No PMID Cancer type Group Drug # Res # NRes % Mut/Res % Mut/NRes % Diff (R vs NR) Pval Anno
125765070Non-small cell lung cancer (NSCLC)allAnti-PD-1 (pembrolizumab) 14170001
225765070Non-small cell lung cancer (NSCLC)smokingAnti-PD-1 (pembrolizumab) 1030001
325765070Non-small cell lung cancer (NSCLC)non-smokingAnti-PD-1 (pembrolizumab) 4140001
426359337MelanomaallAnti-CTLA-4 (ipilimumab) 277301.4-1.41
526359337MelanomaBRAFiAnti-CTLA-4 (ipilimumab) 0140001
626359337Melanomanon-BRAFiAnti-CTLA-4 (ipilimumab) 275901.7-1.71
726997480MelanomaallAnti-PD-1 (pembrolizumab and nivolumab)21170001
826997480MelanomaMAPKiAnti-PD-1 (pembrolizumab and nivolumab)860001
926997480Melanomanon-MAPKiAnti-PD-1 (pembrolizumab and nivolumab)13110001
1028552987Urothelial cancerallAnti-PD-L1 (atezolizumab) 9160001
1128552987Urothelial cancersmokingAnti-PD-L1 (atezolizumab) 590001
1228552987Urothelial cancernon-smokingAnti-PD-L1 (atezolizumab) 470001
1329033130MelanomaallAnti-PD-1 (nivolumab) 38272.602.61
1429033130MelanomaNIV3-PROGAnti-PD-1 (nivolumab) 22134.504.51
1529033130MelanomaNIV3-NAIVEAnti-PD-1 (nivolumab) 16140001
1629301960Clear cell renal cell carcinoma (ccRCC)allAnti-PD-1 (nivolumab) 11130001
1729301960Clear cell renal cell carcinoma (ccRCC)VEGFRiAnti-PD-1 (nivolumab) 610001
1829301960Clear cell renal cell carcinoma (ccRCC)non-VEGFRiAnti-PD-1 (nivolumab) 5120001
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of DKK3. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene.
> Lymphocyte
 
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of DKK3. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by DKK3.
> Immunoinhibitor
> Immunostimulator
> MHC molecule
> Immunoinhibitor
 
> Immunostimulator
 
> MHC molecule
 
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of DKK3. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene.
> Chemokine
> Receptor
> Chemokine
 
> Receptor
 
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Distribution of DKK3 expression across immune and molecular subtypes.
> Immune subtype
> Molecular subtype
> Immune subtype
 
> Molecular subtype
 
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Associations between DKK3 and clinical features.
> Overall survival analysis
> Cancer stage
> Tumor grade
> Overall survival
 
> Stage
 
> Grade
 
Summary
SymbolDKK3
Namedickkopf WNT signaling pathway inhibitor 3
Aliases REIC; regulated in glioma; dickkopf (Xenopus laevis) homolog 3; dickkopf 3 homolog (Xenopus laevis); RIG-lik ......
Chromosomal Location11p15.3
External Links HGNC, NCBI, Ensembl, Uniprot, GeneCards
Content Drugs targeting DKK3 collected from DrugBank database.
> Drugs from DrugBank database
 

There is no record.